<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00951366</url>
  </required_header>
  <id_info>
    <org_study_id>X08-07-0335</org_study_id>
    <nct_id>NCT00951366</nct_id>
  </id_info>
  <brief_title>Bronchopulmonary Disease (BPD) Patient Registry</brief_title>
  <acronym>CHILD</acronym>
  <official_title>The Center for Healthy Infant Development (Child) Clinic Patient Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the Bronchopulmonary Dysplasia (BPD) Patient Registry is to collect data on&#xD;
      individuals with neonatal lung disease to better understand the illness and ultimately&#xD;
      improve their care and survival. The Patient Registry was established in 2008 as a means to&#xD;
      monitor important trends in the BPD population and to improve understanding, treatment, and&#xD;
      survival.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CHILD Clinic Patient Registry is an observational study designed to identify&#xD;
      epidemiologic and genetic factors associated with chronic lung disease in former preterm&#xD;
      infants or those with lung disease in the neonatal period.The Patient Registry is used by&#xD;
      both clinicians and researchers to better understand BPD and to improve care of individuals&#xD;
      with BPD. It is used to assess phenotype and genotype information from former preterm infants&#xD;
      with lung disease. Data in the Patient Registry will be analyzed and an regular report of BPD&#xD;
      health trends will be created. Using this information, BPD clinicians can address quality&#xD;
      improvement initiatives, and examine changing health care issues, including nutritional&#xD;
      status, infection control, pulmonary treatment, metabolic and associated genetic variants.&#xD;
      The Patient Registry will also play an important role in directing clinical care and in the&#xD;
      design of clinical research studies. Researchers use the registry to help in investigating&#xD;
      various aspects of neonatal lung diseases like BPD, including medications, diagnostic&#xD;
      procedures, and eligibility for clinical trials.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Anticipated">January 1, 2099</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2099</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>21 Years</target_duration>
  <primary_outcome>
    <measure>Lung function</measure>
    <time_frame>Up to 35 years of age</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Bronchopulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Bronchopulmonary Dysplasia (BPD)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient Registry</intervention_name>
    <description>The CHILD Clinic Patient Registry is an observational study designed to identify epidemiologic and genetic factors associated with chronic lung disease in former preterm infants or those with lung disease in the neonatal period.</description>
    <arm_group_label>Bronchopulmonary Dysplasia (BPD)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Buccal swabs&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Bronchopulmonary Dysplasia (BPD) patients will be approached during clinical visit and&#xD;
        inpatient hospitalizations.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Neonatal respiratory disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lystra Hayden, MD, MMSc</last_name>
    <email>Lystra.Hayden@childrens.harvard.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lystra Hayden, MD, MMSc</last_name>
      <phone>617-355-1900</phone>
      <email>Lystra.Hayden@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Hayden Lystra, MD, MMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Annesi CA, Levin JC, Litt JS, Sheils CA, Hayden LP. Long-term respiratory and developmental outcomes in children with bronchopulmonary dysplasia and history of tracheostomy. J Perinatol. 2021 Jul 21. doi: 10.1038/s41372-021-01144-0. [Epub ahead of print]</citation>
    <PMID>34290373</PMID>
  </reference>
  <results_reference>
    <citation>Levin JC, Sheils CA, Gaffin JM, Hersh CP, Rhein LM, Hayden LP. Lung function trajectories in children with post-prematurity respiratory disease: identifying risk factors for abnormal growth. Respir Res. 2021 May 10;22(1):143. doi: 10.1186/s12931-021-01720-0.</citation>
    <PMID>33971884</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 3, 2009</study_first_submitted>
  <study_first_submitted_qc>August 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2009</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Lystra Hayden</investigator_full_name>
    <investigator_title>Instructor in Pediatrics</investigator_title>
  </responsible_party>
  <keyword>premature birth</keyword>
  <keyword>neonatal respiratory distress</keyword>
  <keyword>chronic lung disease</keyword>
  <keyword>epidemiologicfactors</keyword>
  <keyword>genetic factors</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

